Currently out of the existing stock ratings of Chris Lewis, 25 are a BUY (100%).

Chris Lewis

Work Performance Price Targets & Ratings Chart

Analyst Chris Lewis, carries an average stock price target met ratio of 100% that have a potential upside of 21.42% achieved within 172 days. Previously, Chris Lewis worked at ROTH MKM, FIRST ANALYSIS.

Chris Lewis’s has documented 67 price targets and ratings displayed on 12 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on AXGN, Axogen at 12-Sep-2017.

Wall Street Analyst Chris Lewis

Analyst best performing recommendations are on EXAS (EXACT SCIENCES).
The best stock recommendation documented was for GKOS (GLAUKOS CORP) at 4/14/2016. The price target of $24 was fulfilled within 20 days with a profit of $5.77 (31.65%) receiving and performance score of 15.83.

Average potential price target upside

ALGN Align Technology EXAS EXACT Sciences GKOS Glaukos Corp LMAT LeMaitre Vascular MASI Masimo CUTR Cutera AXGN Axogen IRM Iron Mountain NEO NeoGenomics CGNT Cognyte Software Ltd ICUI ICU Medical IRMD Iradimed Co

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 21-Oct-2025

$175

$25.11 (16.75%)

$188

Buy Since 25-Mar-2025

$200

$50.11 (33.43%)

$200

10 days ago
(22-Oct-2026)

11/17 (64.71%)

$44.49 (28.61%)

180

Buy Since 01-May-2025

$205

$55.11 (36.77%)

$235

11 days ago
(21-Oct-2026)

17/57 (29.82%)

$53.63 (35.43%)

95

Buy Since 18-Oct-2017

$162

$12.11 (8.08%)

$250

17 days ago
(15-Oct-2026)

20/30 (66.67%)

$12.66 (8.48%)

101

Buy Since 17-Oct-2025

$215

$65.11 (43.44%)

$172

18 days ago
(14-Oct-2026)

3/5 (60%)

$70.56 (48.85%)

40

Show more analysts

Please expand the browser size to see the chart

✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?